Acticor Biotech (XPAR:ALACT) Operating Cash Flow per Share : €-1.23 (TTM As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech Operating Cash Flow per Share?

Acticor Biotech's operating cash flow per share for the six months ended in Jun. 2023 was €-0.68. Acticor Biotech's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was €-1.23.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -41.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Acticor Biotech's Operating Cash Flow per Share or its related term are showing as below:

XPAR:ALACT' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -50.4 Med: -45.95 Max: -41.5
Current: -41.5

During the past 6 years, Acticor Biotech's highest 3-Year average Operating Cash Flow per Share Growth Rate was -41.50% per year. The lowest was -50.40% per year. And the median was -45.95% per year.

XPAR:ALACT's 3-Year OCF Growth Rate is ranked worse than
86.15% of 1235 companies
in the Biotechnology industry
Industry Median: 3.3 vs XPAR:ALACT: -41.50

Acticor Biotech Operating Cash Flow per Share Historical Data

The historical data trend for Acticor Biotech's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech Operating Cash Flow per Share Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.52

-0.41

-0.64

-1.77

-1.15

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-0.54	-0.77	-0.60	-0.55	-0.68

Competitive Comparison of Acticor Biotech's Operating Cash Flow per Share

For the Biotechnology subindustry, Acticor Biotech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Acticor Biotech's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acticor Biotech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Acticor Biotech's Price-to-Operating-Cash-Flow falls into.

Acticor Biotech Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Acticor Biotech's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	-12.104	/	10.546
	=	-1.15

Acticor Biotech's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	-7.949	/	11.632
	=	-0.68

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-1.23

Acticor Biotech Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines